Zephyr AI
Dallas, US · Founded 2021 · Delaware corporation · 8 known investors
Find your way into Zephyr AI
253 people in our graph share verified history with the Zephyr AI team — schools, employers, funds. One of them is your warm intro.
Dylan Fieldunlockedknows Grant Verstandig · together at Brown University (overlapped)
knows the team · via Zephyr AI
knows the team · via Brighton Park Capital
×3knows the team · via Brown University
×6knows the team · via Red Cell Incubation
Zephyr AI is a healthcare technology company. The provided page content is a biography of Grant Verstandig and Red Cell Partners rather than a description of Zephyr AI itself, so it offers no usable detail about Zephyr AI's own products or market.
Founders & leadership
Zephyr AI was founded in 2021 by Grant Verstandig.
GV
Grant Verstandigin𝕏FounderDirector of Zephyr AI, a healthcare technology company. Specializes in healthcare IT and early-stage ventures.
YB
Yisroel BrumerNamed on SEC filing
JS
Jeff ShermanNamed on SEC filing
DM
David MorganNamed on SEC filing
KS
Ken SametNamed on SEC filing
SB
Sol BarerNamed on SEC filing
JT
John TiernanNamed on SEC filing
JR
Jack RoweNamed on SEC filing
Investors · 8
Also in the syndicate · 6
Eli LillyEli Lilly & CompanyEPIQ Capital GroupLernerleadM-CorleadRevolution Growth
Reported raises · per SEC filings
Form D private placements$129.7M disclosed across 2 rounds · 2022–2023
▶$111.4MraisedMar 2024 · 30 investors · BiotechnologyRule 506(b)
▶$111.4MraisedMar 2024 · 30 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Grant VerstandigDirector
- Roger Ferguson, Jr.Director
- Ken SametDirector
- Jeff ShermanExecutive Officer
- Steve MurrayDirector
- Jack RoweDirector
- Rob MyersExecutive Officer
- Sol BarerDirector
- Moncef SlaouiDirector
- Yisroel BrumerDirector
- Rachael BrakeExecutive Officer
- Offering amount
- $120.7M
- Amount sold
- $111.4M
- First sale
- Oct 2023
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
▶$18.4MraisedApr 2022 · 31 investors · BiotechnologyRule 506(b)
▶$18.4MraisedApr 2022 · 31 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Yisroel BrumerDirector
- Jeff ShermanExecutive Officer
- David MorganExecutive Officer
- Ken SametDirector
- Sol BarerDirector
- Grant VerstandigDirector
- John TiernanExecutive Officer
- Jack RoweDirector
- Offering amount
- $19.7M
- Amount sold
- $18.4M
- First sale
- Jan 2022
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 2
by search overlap
Recursion (NASDAQ: RXRX)11 shared keywordsRecursion applies computational and data-driven approaches to biological science, aiming to accelerate drug discovery and develop new treatments. The company combines life scientists and software engineers to solve problems at the intersection of biology and technology.
Hugging Face11 shared keywordsHugging Face is a collaboration platform that hosts and provides access to machine learning models, datasets, and applications. It offers both open-source tools for the ML community and paid compute and enterprise solutions for teams building AI applications.
Companies competing with Zephyr AI for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Zephyr AI do?
- Zephyr AI is a healthcare technology company. The provided page content is a biography of Grant Verstandig and Red Cell Partners rather than a description of Zephyr AI itself, so it offers no usable detail about Zephyr AI's own products or market.
- Who founded Zephyr AI?
- Zephyr AI was founded by Grant Verstandig in 2021.
- Who are Zephyr AI's investors?
- Zephyr AI's investors include Revolution, Medicxi.
- How much funding has Zephyr AI raised?
- Zephyr AI has disclosed $129.7M raised across 2 rounds.
- Where is Zephyr AI headquartered?
- Zephyr AI is headquartered in Dallas, US.